Modulation of tau tubulin kinases (TTBK1 and TTBK2) impacts ciliogenesis.
Bashore, F.M., Marquez, A.B., Chaikuad, A., Howell, S., Dunn, A.S., Beltran, A.A., Smith, J.L., Drewry, D.H., Beltran, A.S., Axtman, A.D.(2023) Sci Rep 13: 6118-6118
- PubMed: 37059819 
- DOI: https://doi.org/10.1038/s41598-023-32854-4
- Primary Citation of Related Structures:  
7ZHN, 7ZHO, 7ZHP, 7ZHQ - PubMed Abstract: 
Tau tubulin kinase 1 and 2 (TTBK1/2) are highly homologous kinases that are expressed and mediate disease-relevant pathways predominantly in the brain. Distinct roles for TTBK1 and TTBK2 have been delineated. While efforts have been devoted to characterizing the impact of TTBK1 inhibition in diseases like Alzheimer's disease and amyotrophic lateral sclerosis, TTBK2 inhibition has been less explored. TTBK2 serves a critical function during cilia assembly. Given the biological importance of these kinases, we designed a targeted library from which we identified several chemical tools that engage TTBK1 and TTBK2 in cells and inhibit their downstream signaling. Indolyl pyrimidinamine 10 significantly reduced the expression of primary cilia on the surface of human induced pluripotent stem cells (iPSCs). Furthermore, analog 10 phenocopies TTBK2 knockout in iPSCs, confirming a role for TTBK2 in ciliogenesis.
Organizational Affiliation: 
Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.